She devised a personalized treatment plan, and after just four sessions, I began to see a remarkable difference in my skin
Adherence data across medication classes consistently shows that less frequent dosing correlates with better compliance
doi: 10.1038/nature19323 225 SheaT
Members following the tirzepatide protocol reported outcomes consistent with the Surpass-1 clinical trial, which showed up to 31% reduction in fat mass over six months
Sources: Alzheimer's Disease Study Multicenter, randomized, double-blind, placebo-controlled clinical trial for the efficacy of acetyl-L-carnitine in Alzheimer's disease
Troubleshooting insufficient weight loss If weight loss stalls despite being at target doses, evaluate compliance first